VBVasily Belov

Vasily Belov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vasily Belov has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • PET Mapping of Receptor Occupancy Using Joint Direct Parametric Reconstruction

    by Thibault Marin, Vasily Belov, Yanis Chemli, Jinsong Ouyang, Yassir Najmaoui, Georges El Fakhri, Sridhar Duvvuri, Philip Iredale, Nicolas J. Guehl, Marc D. Normandin, et al.

    Receptor occupancy (RO) studies using PET neuroimaging play a critical role in the development of drugs targeting the central nervous system (CNS). The conventional approach to estimate drug receptor occupancy consists in estimation of binding potential changes between two PET scans (baseline and post-drug injection). This estimation is typically performed separately for each scan by first reconstructing dynamic PET scan data before fitting a kinetic model to time activity curves. This approach fails to properly model the noise in PET measurements, resulting in poor RO estimates, especially in low receptor density regions. Objective: In this work, we evaluate a novel joint direct parametric reconstruction framework to directly estimate distributions of RO and other kinetic parameters in the brain from a pair of baseline and post-drug injection dynamic PET scans. Methods: The proposed method combines the use of regularization on RO maps with alternating optimization to enable estimation of occupancy even in low binding regions. Results: Simulation results demonstrate the quantitative improvement of this method over conventional approaches in terms of accuracy and precision of occupancy. The proposed method is also evaluated in preclinical in-vivo experiments using 11C-MK-6884 and a muscarinic acetylcholine receptor 4 positive allosteric modulator drug, showing improved estimation of receptor occupancy as compared to traditional estimators. Conclusion: The proposed joint direct estimation framework improves RO estimation compared to conventional methods, especially in intermediate to low-binding regions. Significance: This work could potentially facilitate the evaluation of new drug candidates targeting the CNS.


  • Open Access

    Modeling of soot formation in a tractor diesel engine running on methanol and methyl ether of rapeseed oil

    by A S Yurlov, O P Lopatin, V A Likhanov, V V Belov, A V Stepanov

    When studying the process of formation of soot nuclei in a flame, it is necessary to pay attention to the sequence of chemical transformations of fuel molecules in order to determine the concentration of dangerous toxic components in the exhaust gases (EG) of a diesel internal combustion engine (DICE). Today, numerous studies are being conducted to establish a detailed kinetic mechanism of the process of carbon condensation and gasification in a DICE. Despite significant progress in understanding the essence and some regularities of the processes occurring in a DICE, it is not yet possible to compile a numerical model that can predict the main indicators of soot content. A semi-empirical mathematical model of soot formation and burnout in a DICE is presented, compiled on the basis of a kinetic model that reliably predicts the dynamics of soot content in the cylinder and the concentration of soot in the EG in a wide range of operating modes of a DICE. The model makes it possible to facilitate the process of studying the factors of soot formation and reduce the cost of conducting experimental studies related to the search for alternative fuels and improving the design of a DICE, optimizing the operation of fuel supply and gas distribution systems.

  • Open Access

    [18F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models

    by Tuo Shao, Zhen Chen, Jian Rong, Vasily Belov, Jiahui Chen, Andre Jeyarajan, Xiaoyun Deng, Hualong Fu, Qingzhen Yu, Steve H. Rwema, et al.


  • Open Access

    Large-Volume Intrathecal Administrations: Impact on CSF Pressure and Safety Implications

    by Vasily Belov, Janine Appleton, Stepan Levin, Pilar Giffenig, Beata Durcanova, Mikhail Papisov

    The increasing number of studies demonstrates the high potency of the intrathecal (IT) route for the delivery of biopharmaceuticals to the central nervous system (CNS). Our earlier data exhibited that both the infused volume and the infusion rate can regulate the initial disposition of the administered solute within the cerebrospinal fluid (CSF). This disposition is one of key factors in defining the subsequent transport of the solute to its intended target. On the other hand, fast additions of large volumes of liquid to the CSF inevitably raise the CSF pressure [a.k.a. intracranial pressure (ICP)], which may in turn lead to adverse reactions if the physiologically delimited threshold is exceeded. While long-term biological effects of elevated ICP (hydrocephalus) are known, the safety thresholds pertaining to short-term ICP elevations caused by IT administrations have not yet been characterized. This study aimed to investigate the dynamics of ICP in rats and non-human primates (NHPs) with respect to IT infusion rates and volumes. The safety regimes were estimated and analyzed across species to facilitate the development of translational large-volume IT therapies. The data revealed that the addition of a liquid to the CSF raised the ICP in a rate and volume-dependent manner. At low infusion rates (<0.12 ml/min in rats and <2 ml/min in NHPs), NHPs and rats displayed similar tolerance patterns. Specifically, safe accommodations of such added volumes were mainly facilitated by the accelerated pressure-dependent CSF drainage into the blood, with I stabilizing at different levels below the safety threshold of 28 ± 4 mm Hg in rats and 50 ± 5 mm Hg in NHPs. These ICPs were safely tolerated for extended durations (of at least 2–25 min). High infusion rates (including boluses) caused uncompensated exponential ICP elevations rapidly exceeding the safety thresholds. Their tolerance was species-dependent and was facilitated by the compensatory role of the varied components of craniospinal compliance while not excluding the possibility of other contributing factors. In conclusion, large volumes of liquids can safely be delivered via IT routes provided that ICP is monitored as a safety factor and cross-species physiological differences are accounted for.


  • Open Access

    Large-volume intrathecal administrations: impact on CSF pressure and safety implications

    by Vasily Belov, Janine Appleton, Stephan Levin, Pilar Giffenig, Beata Durcanova, Mikhail Papisov

    The increasing number of studies demonstrates the high potency of the intrathecal (IT) route for the delivery of biopharmaceuticals to the central nervous system (CNS). Our earlier data exhibited that both the infused volume and the infusion rate can regulate the initial disposition of the administered solute within the cerebrospinal fluid (CSF). On the other hand, fast additions of large volumes of liquid to the CSF inevitably raise the intracranial pressure (ICP), which may in turn lead to adverse reactions if the physiologically delimited threshold is exceeded. While long-term biological effects of elevated ICP (hydrocephalus) are known, the safety thresholds pertaining to short-term ICP elevations caused by IT infusions have not yet been characterized. This study aimed to investigate the dynamics of ICP in rats and non-human primates (NHPs) with respect to IT infusion rates and volumes. The data revealed that the addition of a liquid to the CSF raised the ICP in a rate and volume-dependent manner. At low infusion rates (<0.12 ml/min in rats and <2 ml/min in NHPs), NHPs and rats displayed similar tolerance patterns for extended durations. Specifically, safe accommodations of such added volumes were mainly facilitated by the accelerated pressure-dependent CSF drainage into the blood, with ICPs stabilizing at different levels below the safety threshold of 28+/-4 mm Hg in rats and 50+/-5 mm Hg in NHPs. High infusion rates caused uncompensated ICP elevations rapidly exceeding the safety thresholds. Their tolerance was species-dependent and was facilitated by the compensatory role of the varied components of craniospinal compliance while not excluding the possibility of other contributing factors. In conclusion, large volumes of liquids can safely be delivered via IT routes provided that ICP is monitored as a safety factor and cross-species physiological differences are accounted for.

  • [18F]-Alfatide PET imaging of integrin αvβ3 for the non-invasive quantification of liver fibrosis

    by Tuo Shao, Zhen Chen, Vasily Belov, Xiaohong Wang, Steve H. Rwema, Viksit Kumar, Hualong Fu, Xiaoyun Deng, Jian Rong, Qingzhen Yu, et al.


  • Open Access

    The Configuration of the Perivascular System Transporting Macromolecules in the CNS

    by Beata Durcanova, Janine Appleton, Nyshidha Gurijala, Vasily Belov, Pilar Giffenig, Elisabeth Moeller, Matthew Hogan, Fredella Lee, Mikhail Papisov

    Large blood vessels entering the CNS are surrounded by perivascular spaces that communicate with the cerebrospinal fluid and, at their termini, with the interstitial space. Solutes and particles can translocate along these perivascular conduits, reportedly in both directions. Recently, this prompted a renewed interest in the intrathecal therapy delivery route for CNS-targeted therapeutics. However, the extent of the CNS coverage by the perivascular system is unknown, making the outcome of drug administration to the CSF uncertain. We traced the translocation of model macromolecules from the CSF into the CNS of rats and non-human primates. Conduits transporting macromolecules were found to extend throughout the parenchyma from both external and internal (fissures) CNS boundaries, excluding ventricles, in large numbers, on average ca. 40 channels per mm2 in rats and non-human primates. The high density and depth of extension of the perivascular channels suggest that the perivascular route can be suitable for delivery of therapeutics to parenchymal targets throughout the CNS.


  • Synthesis and Preliminary Evaluations of a Triazole-Cored Antagonist as a PET Imaging Probe ([18F]N2B-0518) for GluN2B Subunit in the Brain

    by Hualong Fu, Weiting Tang, Zhen Chen, Vasily V. Belov, Genwei Zhang, Tuo Shao, Xiaofei Zhang, Qingzhen Yu, Jian Rong, Xiaoyun Deng, et al.

    GluN2B is the most studied subunit of N-methyl-d-aspartate receptors (NMDARs) and implicated in the pathologies of various central nervous system disorders and neurodegenerative diseases. As pan NMDAR antagonists often produce debilitating side effects, new approaches in drug discovery have shifted to subtype-selective NMDAR modulators, especially GluN2B-selective antagonists. While positron emission tomography (PET) studies of GluN2B-selective NMDARs in the living brain would enable target engagement in drug development and improve our understanding in the NMDAR signaling pathways between normal and disease conditions, a suitable PET ligand is yet to be identified. Herein we developed an 18F-labeled potent antagonist, 2-((1-(4-[18F]fluoro-3-methylphenyl)-1H-1,2,3-triazol-4-yl)methoxy)-5-methoxypyrimidine ([18F]13; also called [18F]N2B-0518) as a PET tracer for imaging the GluN2B subunit. The radiofluorination of [18F]13 was efficiently achieved by our spirocyclic iodonium ylide (SCIDY) method. In in vitro autoradiography studies, [18F]13 displayed highly region-specific binding in brain sections of rat and nonhuman primate, which was in accordance with the expression of GluN2B subunit. Ex vivo biodistribution in mice revealed that [18F]13 could penetrate the blood-brain barrier with moderate brain uptake (3.60% ID/g at 2 min) and rapid washout. Altogether, this work provides a GluN2B-selective PET tracer bearing a new chemical scaffold and shows high specificity to GluN2B subunit in vitro, which may pave the way for the development of a new generation of GluN2B PET ligands.


  • Awake animal functional imaging to investigate the effects of general anesthesia on brain

    by Ilker Ozsahin, Codi Gharagouzloo, Vasily Belov, Nathaniel M. Alpert, Georges El Fakhri

    General anesthesia has been performed reliably for nearly 170 years even though its exact mechanism is still unknown. To date, almost all small animal studies to investigate the effects of general anesthesia have been done under anesthesia and it prevents the quantitative analysis because of anesthesia itself effects the neurofunctional parameters under study. Here we have used an awake animal imaging method to study and compare cerebral glucose utilization in the awake and anesthetized states. We have shown that the general anesthesia has a profound effect on rat brain and it depends on the type and the dose of anesthetic drug.